EDSA — Edesa Biotech Share News
0.000.00%
Edesa Biotech Inc expected to post a loss of 54 cents a share - Earnings Preview
Edesa Biotech Inc expected to post a loss of 52 cents a share - Earnings Preview
Edesa Biotech Inc expected to post a loss of 58 cents a share - Earnings Preview
Edesa Biotech Inc expected to post a share - Earnings Preview
Brief: Edesa Biotech Says BARDA Selects Co's Drug For U.S. Funded Platform Trial In General ARDS
Edesa Biotech Inc reports results for the quarter ended in March - Earnings Summary
Edesa Biotech Inc expected to post a loss of 69 cents a share - Earnings Preview
Edesa Biotech Inc reports results for the quarter ended in December - Earnings Summary
Brief: Edesa Reported Net Loss Of $1.7 Million, Or $0.54 Per Common Share For Quarter Ended Dec 31, 2023
Edesa Biotech Inc expected to post a loss of $1.21 a share - Earnings Preview
Edesa Biotech Inc reports results for the quarter ended in September - Earnings Summary
Edesa Biotech Inc expected to post a loss of 71 cents a share - Earnings Preview
Brief: Edesa Biotech Inc - Intends To Effect A One-For-Seven Reverse Share Split Of Its Common Shares
Edesa Biotech Inc reports results for the quarter ended in June - Earnings Summary
Edesa Biotech Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Edesa Biotech Inc Says Board Has Appointed Stephen Lemieux To Role Of CFO , Effective July 15
Brief: Edesa Biotech Receives Letter From Nasdaq Co Not In Compliance With Minimum Bid Price Requirement
Brief: Edesa Biotech CFO To Retire Effective July 15
Edesa Biotech Inc reports results for the quarter ended in March - Earnings Summary